Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID TrialPaulo M. Hoff, Brigitte Van Eyll, Carlos H. Barrios et al.|Journal of Clinical Oncology|2014Cited by 48